The Bacillus subtilis acsA (acetyl coenzyme A synthetase) and acuABC (acetoin utilization) genes were previously identified in the region downstream from the ccpA gene, which encodes a protein required for catabolite repression of the amyE (a-amylase) gene. The acsA and acuABC genes are divergently transcribed, with only 20 bp separating the -35 sequences of their promoters. Expression of these genes was maximal in stationary phase and was repressed by the addition of glucose to the growth medium. Two sites resembling amyO, the cis-acting regulatory target site for amyE, were identified in the acsA and acuABC promoter regions. Glucose repression of acsA and acuABC transcription was dependent on both CcpA and the amyO-like sequences.
The presence of readily metabolizable carbon sources in the growth medium generally results in repression of genetic systems for utilization of secondary carbon sources and activation of pathways involved in excretion of excess carbon. In Bacillus species, the mechanisms for response to carbon excess are not well understood, although it is evident that cyclic AMP is not the effector, as it is in Escherichia coli (for a review, see reference 2). A great deal of effort has been devoted to identification of elements involved with catabolite regulation. The amyE gene, encoding a-amylase, contains a cis-acting element, designated amyO, which is required for glucose repression (22, 28) . Elements resembling amyO have been identified in a large number of genes from gram-positive species (11, 28) , and mutations in these elements in the xyl, hut, and gnt operons (13, 15, 19, 23) , as well as amyE, result in loss of glucose repression. The ccpA gene product, which is closely related to DNA-binding proteins in the E. coli LacI-GalR family, was identified as a trans-acting repressor of amyE (10) and was shown to bind to amyO (2a) . Mutations in ccpA relieve glucose repression of amyE as well as of levC, gnt and xyl (4, 12, 17) .
CcpA also appears to act as a positive regulator for acetolactate synthase (alsS) (24, 29, 30) and acetate kinase (ackA) (6) , which are involved in acetoin biosynthesis and acetate excretion, respectively. The ackA promoter region contains two upstream sites which closely resemble the amyO operator site, suggesting that CcpA may interact directly with ackA DNA. It therefore appears that CcpA acts as both a positive and a negative regulator of gene expression.
Two divergent transcriptional units, acsA and acuABC, encoding products involved in utilization of acetate and acetoin, respectively, were identified in the region of the Bacillus subtilis chromosome downstream of the ccpA gene (7) . The acsA gene encodes acetyl coenzyme A synthetase; the precise roles of the three genes in the acu operon are not known, but insertional inactivation of acuA results in poor utilization of acetoin and butanediol during growth and sporulation. The steady-state levels of the acsA and acuABC transcripts are reduced during growth in excess glucose (7) . Since acsA and acuABC are involved in utilization of secondary carbon sources, we considered the possibility that these genes, like amyE, might be subject to repression by CcpA. In support of this idea, two sequences which resemble the amyO operator sequence were identified in the acsA and acuABC promoter regions. In this study, the expression of these transcriptional units and the role of CcpA in their regulation were investigated.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The bacterial strains used are listed in Table 1 . B. subtilis strains were grown on tryptose blood agar base (TBAB) plates (Difco) or in nutrient sporulation medium (NSM) (25) . Defined medium was TSS (3), with NH4Cl as the nitrogen source and the following carbon sources: Casamino Acids (Difco), used at 1% (wt/vol); glucose or lactate, used as the sole carbon source at 0.2%; and glucose added at 1% for tests of glucose repression of gene expression. The following antibiotics (Sigma Chemical Co.) were used at the concentrations indicated: ampicillin, 50 ,u.g/ml; chloramphenicol, 5 ,ug/ml for selection and 0.1 jig/ml for induction; erythromycin, 1 ,ug/ml; lincomycin 25 jig/ml; and spectinomycin, 200 jig/ml. X-Gal (5-bromo-4-chloro-3-indolyl-P-D-galactopyranoside) was used at 40 ,ug/ml as an indicator of ,B-galactosidase activity.
Genetic techniques. Restriction endonucleases and DNAmodifying enzymes were purchased from New England BioLabs (Beverly, Mass.) and used as described by the manufacturer. DNA sequencing, with M13 single-stranded DNA or double-stranded plasmid DNA templates, was carried out by standard dideoxynucleotide procedures with Sequenase (United States Biochemicals). Synthetic oligonucleotides were purchased from Genosys (Woodlands, Tex.). DNA amplification was carried out by PCR with a GeneAmp kit (Perkin-Elmer Cetus). B. subtilis transformation was done as previously described (9) .
Construction of lacZ fusions. acsA-lacZ and acuA-lacZ transcriptional fusions were generated by insertion of the 1.8-kb Stul-HindIII fragment ( Fig. 1 ) into plasmid pZA327 (20) (20) fusions were transferred into specialized transducing phage SP,B by homologous recombination between the plasmid and the prophage contained in strain ZB307A, and the resulting phage were purified by passage through strain ZB449 (SPP cured) before introduction into isogenic wild-type or CcpAhost strains. The CcpA-strain contained the gra-26 ccpA::Tn9171ac insertion (10), with the ern and lac portions replaced by a spc cassette (27) , conferring a spectinomycinresistant (Spcr) phenotype. 3-Galactosidase assays were carried out as described by Miller (18) , using toluene to permeabilize the cells. In all experiments in which fusion expression was measured, cultures were maintained in early exponential growth for several generations by serial dilution in the appropriate growth medium, so that adaptation to the growth medium was complete before the start of the experiment.
Construction of operator mutants. Mutations in the 01 and 02 amyO-like sequences were generated by PCR. Synthetic oligonucleotides 1 through 6 ( Fig. 1) were used in different combinations to generate wild-type or mutant fragments, which were inserted into plasmid pZA327 digested with Sall. Template DNA for PCR was CsCl2-purified plasmid pLG3.3, which contains the 3.3-kb EcoRI fragment from the acsAacuABC region (7) . Amplification with oligonucleotides 2 plus 1, followed by digestion with Sall, yielded a 620-bp wild-type insert fragment. The 01-mutant was generated by separate amplification reactions with oligonucleotides 2 plus 6 and 5 plus 1, followed by digestion with Sall and HindIII, to generate 230-bp Sal-HindIII and 390-bp HindIII-Sall fragments; these two fragments together correspond to the 620-bp SalI fragment generated above, with a new HindIII site introduced at the position of the 01 sequence. The 02-mutant was generated by separate amplification reactions with oligonucleotides 2 plus 4 and 3 plus 1, followed by digestion with SalI and NsiI, to generate fragments that were 350 and 270 bp in length; these two fragments together correspond to the 620-bp Sall fragment, with a new NsiI site introduced at the position of the P P (Hd) (Nal) 02 sequence. The DNA sequence of the resulting clones was determined to ensure that no unexpected sequence alterations were introduced during the amplification process. DNA fragments containing the wild-type or mutant operator sequences were introduced into plasmid pZA327 in both orientations so that the acsA or acuABC promoter was fused to lacZ; the orientation of the insertions was determined by restriction endonuclease mapping. The resulting fusions were then transferred into phage SP, by homologous recombination and introduced into isogenic wild-type and CcpA-host strains for measurement of P-galactosidase synthesis.
RESULTS
acsA-lacZ expression. A fusion of the acsA transcriptional unit to a promoterless lacZ gene was introduced in single copy into the B. subtilis chromosome by using specialized transducing phage SP,B. Expression of the fusion, in either a wild-type or CcpA-host strain, was monitored during growth in various media. As shown in Fig. 2 , expression of the acsA-lacZ fusion in a wild-type strain grown in NSM was very low early in the growth cycle and was partially induced in mid-logarithmic growth; maximal induction occurred as the cells entered into stationary phase (TO), and ,B-galactosidase levels were highest at around 2 h after entry into stationary phase. Addition of glucose to the medium reduced expression of the fusion in a wild-type strain, indicating that acsA is subject to catabolite repression. These results are in agreement with primer extension analysis of acsA transcription, which showed that the steady-state level of the mRNA is lower in cells grown in the The conditions for acsA expression were further explored by using a defined medium with various carbon sources. Expression in TSS minimal medium with Casamino Acids as the carbon source resulted in a pattern of expression similar to that observed in nutrient broth medium (NSM), except that expression very early in growth was higher in Casamino Acids than in NSM (Fig. 3) . This difference could be due either to the presence in NSM (which contains nutrient broth) of compounds other than amino acids that repress acsA expression or to differences in the composition of the amino acid mixtures. The transient induction in mid-logarithmic growth observed in NSM was also observed in TSS plus Casamino Acids. The basis for this effect is unknown, although one possibility is that it is the consequence of a shift in utilization of different amino acids in the mixture. This pattern of expression was also observed in a CcpA-strain (data not shown). The addition of glucose to TSS plus Casamino Acids resulted in severe repression of acsA-lacZ expression, as observed in NSM, and addition of acetate again had no effect. acuA-lacZ expression. Expression of acuABC was monitored by using a construct containing a transcriptional fusion of the acuA promoter region to lacZ. In NSM (Fig. 4A) , expression was still increasing approximately 4 h after the entry into stationary phase. The addition of glucose resulted in reduced expression, as was observed for acsA; these results are consistent with primer extension analysis of acuABC mRNA levels in cells grown in the presence or absence of excess glucose (7) . Since the acuABC operon is apparently involved in utilization of acetoin and butanediol, the effect of the addition of acetoin to the growth medium was tested; no effect on acuA-lacZ expression was observed, indicating that acetoin does not act as an inducer under these conditions. Transfer of the fusion to a CcpA-strain (Fig. 4B ) resulted in stimulation of expression by glucose, rather than glucose repression, indicating that CcpA is required for glucose repression of acuA as well as acsA.
Effect of mutations in amyO-like sites in acsA and acuABC promoter regions. Since CcpA was shown to be required for glucose repression of acsA and acuABC expression, the promoter regions of these genes were searched for sequences resembling the amyO site identified as the cis-acting regulatory target site for the amyE gene. Two sites, designated 01 and 02, were identified (Fig. SA) acuABC promoter region, between the -35 and -10 sequences, overlapping the -35 sequence. The 02 sequence is located downstream of the acsA transcription start point, at positions +38 to +51; the ATG start of translation is at position +31. The 02 sequence more closely resembles amyO, with only two mismatches. These changes alter the equivalent position in each half-site of the operator. Alteration of this position in the right half-site from A to T in amyO has been shown to have no effect on glucose repression, while a change from A to G causes a 3.5-fold reduction in repression (28) . The 01 sequence contains mainly the central core region of the amyO operator site and deviates from the amyO consensus at positions which are highly conserved.
Mutations in each of these putative operator sites were generated by PCR-mediated oligonucleotide-directed mutagenesis. In both cases, sequence alterations which had been shown to completely inactivate amyO function (28) were selected (Fig. SB) . The 01 mutation contains a single nucleotide substitution and is equivalent to the gra-30 allele of amyO; the 02 mutation contains two substitutions, including the G-to-A substitution of the gra-10 allele.
acsA-lacZ and acuA-lacZ fusions containing each of the operator mutations were constructed and tested for effects on expression. As shown in Fig. 6A the 01-mutation still had no effect on acsA-lacZ expression, whereas expression of the fusion containing the 02-mutation was no longer repressed by glucose and was in fact now activated by glucose. In a CcpA-strain (Fig. 6B) , the 02-fusion exhibited a pattern of expression similar to that of the wild-type and 01-fusions (loss of glucose repression but no enhancement of expression by glucose).
In the case of the acuA-lacZ fusions (Fig. 7A) , the 02-mutation had no effect on expression in a wild-type strain in the presence or absence of glucose, while the 01 mutation had a modest stimulatory effect in the absence of glucose and resulted in a major increase in expression in the presence of glucose. In a CcpA-strain (Fig. 7B) , all three acuA-lacZ fusions exhibited increased expression in the presence of glucose, but this effect was strongest in the 01-mutant. These results indicate that the 01 site operates specifically on glucose repression of acuA expression, while the 02 site operates specifically on repression of acsA expression. Disruption of the appropriate operator site resulted in activation of expression by glucose; this enhancement of expression apparently requires CcpA for acsA but is partially CcpA independent for acuA. 
DISCUSSION
The identification and characterization of additional genes which are subject to glucose repression by CcpA should extend our understanding of the role of CcpA in catabolite regulation in B. subtilis. Two adjacent divergent transcriptional units, acsA and acuABC, involved in utilization of acetate and acetoin, respectively, were identified in the region downstream from ccpA (7). This region also contains two open reading frames with sequence similarity to the B. subtilis and E. coli motAB motility genes (7, 12 ). In the current study, the patterns of expression of the acsA and acuABC transcriptional units were examined. Transcription of the acsA and acuABC genes was shown to be repressed by glucose, and repression required both CcpA and cis-acting operator sites which resemble the amyO operator site previously identified as the regulatory target site for catabolite repression of the amyE gene (22) and subsequently identified in other genes known to be subject to catabolite repression (11, 13, 15, 23, 28) . Direct in TSS-Casamino Acids-glucose medium. The basis for the transient expression during logarithmic growth on amino acids is unknown, but this effect was shown to be independent of both CcpA and the cis-acting operator site involved in repression by glucose, suggesting that there is an additional unknown regulatory mechanism affecting acsA expression during vegetative growth.
It has previously been shown that a large percentage of glucose added to cultures of B. subtilis or B. cereus grown in complex medium is converted to acetate and pyruvate during vegetative growth; excreted acetate is then utilized early during sporulation, after glucose has been depleted (8) . Furthermore, the addition of chloramphenicol to vegetative cells blocked acetate utilization but had no effect on sporulating cells, indicating that the required enzymes are absent in vegetative cells and present in sporulating cells (8) . Acetoin production occurs 1 to 2 h following acetate production, and utilization of acetoin occurs after acetate levels have dropped (14, 26) . Our results on the kinetics of acsA and acuABC expression are in agreement with these data, since acsA expression was maximal at T2, at the point when acetate levels are highest, while acuABC expression occurred later, when acetoin levels are high and acetate levels have dropped. The mechanisms controlling the kinetics of acsA and acuABC expression have not yet been established but are apparently independent of the mechanisms controlling glucose repression, as is also the case for amyE (21, 22) .
Little information about acetate metabolism is available for Bacillus species. Acetate which is excreted during growth is not utilized until after the glucose has been depleted, and the addition of glucose represses oxidation of acetate (8) . In E. coli, characterization of mutants blocked in acetate kinase and phosphotransacetylase synthesis revealed the presence of an alternate acetate utilization pathway mediated by acetyl coenzyme A synthetase; synthesis of this activity was induced by acetate and repressed by glucose (1) . Expression of B. subtilis acsA was also repressed by glucose, but no induction by acetate was detected.
Synthesis of some of the enzymes involved in acetoin utilization has been shown to be induced by acetoin and repressed by glucose (16) . Expression of the acuABC operon, which is involved in acetoin utilization, was shown here to be repressed by glucose, in agreement with previous measurements of acetoin degradation enzyme activities; however, no induction by acetoin was observed. It is possible that the products of this operon are regulated differently from those measured in the previous study. Alternatively, differences in culture conditions may have resulted in changes in the efficiency of acetoin uptake.
The therefore, no evidence for cooperative action of these sequences.
The 02-mutation resulted in stimulation of acs-lacZ expression by glucose, while the 01-mutation resulted in a moderate increase in expression of acu-lacZ in the absence of glucose and a strong increase in expression in the presence of glucose. The enhanced expression of acs-lacZ (02-mutant) in the presence of glucose apparently requires CcpA, while this effect for acu-lacZ (01-mutant) was partially retained in the CcpA-host. One possible explanation for this effect is that the close proximity of the acsA and acu,4BC promoters results in competition between the sites for RNA polymerase when neither promoter is repressed. Inactivation of the 01 site, under conditions in which the acsA promoter is repressed (CcpA+, in the presence of glucose), results in freer access of RNA polymerase to the acuABC promoter, without competition from the acsA promoter. Conversely, inactivation of the 02 site in a glucose-grown CcpA+ strain results in freer access of RNA polymerase to the acsA promoter than in a CcpAmutant. Alternatively, it is possible that the altered operator sites result directly in CcpA-mediated enhancement of expression. In the 01 mutant, interaction of CcpA with 02 is apparently intact, since repression of acsA is maintained; it is possible that interaction of CcpA with a site upstream of the acuABC promoter acts to activate transcription, if the repressive interaction of CcpA with 01 is prevented. Similarly, disruption of 02 might permit enhancement of expression of acsA by CcpA at 01. This model is supported by analysis of the B. subtilis ackA gene, encoding acetate kinase, from which it appears that interaction of CcpA at amyO-like sites upstream of the promoter is required for glucose activation (6) . A third possibility is that growth in the presence of glucose results in production of a signal, such as increased intracellular levels of acetate or acetoin, or pH reduction, which results in induction of expression in the presence of CcpA; the production of the signal could also be partially dependent on functional CcpA. Since CcpA appears to be involved in the response of a number of systems to carbohydrate availability, it is likely that a CcpAmutant would exhibit a variety of physiological perturbations. Separation of the two promoter sequences and construction of a mutant containing both operator site mutations will be necessary to clarify this issue.
This study indicates that CcpA is involved in glucose repression of acsA and acuABC, in addition to amyE, levC, gnt, and xyl. It is apparent that CcpA plays a key role in carbon catabolite regulation of a number of carbon metabolism genes and that a conserved cis-acting sequence acts as the target site for CcpA action. The full extent of the CcpA regulon is not yet known. Sites resembling amyO have been identified in a number of additional catabolite-regulated genes in B. subtilis and other gram-positive species (11, 28) , but the functional role of these sequences has not yet been determined. At least some of these genes are likely to prove to be regulated by CcpA. CcpA is also required for acetoin biosynthesis (10, 29) , and glucose activation of acetate kinase gene expression (6) . It will be of great interest to further explore the role of CcpA in regulation of carbon metabolism in B. subtilis.
